Key result
Female sex was independently associated with a higher risk of developing systemic inflammatory response syndrome on postoperative day 1 and experiencing composite adverse outcomes after cardiac surgery.
Why the study?
Differences in inflammatory responses between men and women may contribute to sex disparities in cardiac surgery outcomes.
Does female sex increase the risk of systemic inflammatory response syndrome and adverse outcomes after cardiac surgery?
Cohort (n=1,005)
No
Does female sex increase the risk of systemic inflammatory response syndrome and adverse outcomes after cardiac surgery?
Female sex is independently associated with a higher risk of postoperative SIRS and poorer outcomes after cardiac surgery, with SIRS mediating over half of this effect.
Answers are grounded in this paper and cite their sources.
May identify women at higher SIRS risk after cardiac surgery; hypothesis-generating for sex-specific trials before practice change.
OBJECTIVES: Differences in inflammatory responses between men and women may contribute to sex disparities in cardiac surgery outcomes. We investigated how sex differences influence systemic inflammatory response syndrome (SIRS) and adverse outcomes after cardiac surgery. METHODS: A single-centre retrospective cohort study of patients undergoing cardiac surgery from 2018 to 2020 was performed. SIRS was defined as per the American College of Chest Physicians/Society of Critical Care Medicine. Predictors of SIRS and composite adverse outcomes (death, transient ischaemic attack/stroke, renal therapy, bleeding, postcardiotomy mechanical circulatory support, prolonged Intensive Care Unit stay) were evaluated using multivariable logistic regression. Mediation effects of SIRS were assessed using structural equation modelling. RESULTS: The cohort included 1005 patients, of whom 299 (29.8%) were women. SIRS occurred in 28.1% of patients, and 12.7% experienced the composite end point. Female sex was significantly associated with SIRS (odds ratio 1.56; 95% confidence interval 1.12-2.18, P = 0.009) and the composite outcome (odds ratio 1.72; 95% confidence interval 1.10-2.69, P = 0.017). Baseline left ventricular dysfunction and intraoperative hyperlactatemia were additional common predictors. SIRS mediated 50.8% of the effect of female sex, 17.0% of left ventricular dysfunction and 30.9% of intraoperative hyperlactatemia on the composite outcome. CONCLUSIONS: Female sex is independently associated with postoperative SIRS and poorer outcomes. Systemic inflammation, preoperative anaemia and procedural hyperlactatemia are potentially modifiable factors in the mechanisms through which female sex appears to worsen outcome after cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Squiccimarro et al. (2025) conducted a cohort in Cardiac surgery and cardiopulmonary bypass (n=1,005). Female sex vs. Male sex was evaluated on Systemic inflammatory response syndrome (SIRS) on postoperative day 1 (OR 1.56, 95% CI 1.12-2.18, p=0.009). Female sex was independently associated with a higher risk of developing systemic inflammatory response syndrome on postoperative day 1 and experiencing composite adverse outcomes after cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: